PUMA BIOTECHNOLOGY, INC. ($PBYI)
Filing Information
| Accession Number | 0001437749-26-000922 |
|---|---|
| Form Type | 4 |
| Filing Date | Jan 9, 2026 |
| Document Date | Jan 6, 2026 |
| Document | View SEC Filing |
Transactions
2
Total Shares
8,987
Total Value
$52,695.52
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
The Reporting Person is the Senior Vice President of Regulatory Affairs of the Issuer. | Common Stock | โ | Jan 6, 2026 | Sale | 3,973 | $5.84 | $23,218.21 | 160,921 | Direct | โ | View Details | |
The Reporting Person is the Senior Vice President of Regulatory Affairs of the Issuer. | Common Stock | โ | Jan 7, 2026 | Sale | 5,014 | $5.88 | $29,477.31 | 155,907 | Direct | โ | View Details |